oloBion
oloBion is a startup dedicated to providing services for drug discovery and translational research in the pharmaceutical and biomedical industries.
Description
oloBion is a startup dedicated to providing services for drug discovery and translational research in the pharmaceutical and biomedical industries. By integrating cutting-edge mass spectrometry and AI technologies, they offer advanced omics and ADME-DMPK services. The company leverages its technology to demonstrate the efficacy and safety of new drug candidates, as well as to identify key biomarkers that guide the development of innovative treatments. Located at the Parc Científic de Barcelona, one of Europe’s premier hubs for scientific innovation, oloBion is at the forefront of accelerating R+D.
Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Biologics
- Advanced omics services
- ADME-DMPK services
In a rapidly evolving pharmaceutical landscape, oloBion stands out as a key provider of specialised services, ensuring that clients receive the precise support needed for their drug discovery and development efforts. For more information, please visit olobion.ai.